About Simtriyo
A new type of treatment for ADHD
ADHD symptoms aren’t driven by one brain chemical. Simtriyo is the first and only FDA-approved ADHD treatment designed to target 3 key neurotransmitters: norepinephrine, dopamine, and serotonin.
navy
interior
60
custom
36

How neurotransmitters impact ADHD

h1
center
text-brand-navy
font-weight-extrabold
16
16
These 3 brain chemicals called neurotransmitters are thought to play a role in ADHD symptoms. They react differently in everyone's brain, which is one of the reasons your ADHD shows up differently than someone else's. Neurotransmitters interact to shape both classic Diagnostic Symptoms, like inattention, hyperactivity/impulsivity, and Associated Symptoms, like emotions, motivation, and task initiation.
text-center
text-brand-navy
font-weight-medium
size-small
link-color-orange
1099px
48
48
60
48
341px
16px
16px
false
row
row
center

Get Simtriyo info at a glance

View the brochure
custom
#002c3e
true
-2
center
custom
50
custom
40
custom
#00613D
#fff
top right
1060px
A once-daily ADHD treatment
Simtriyo is a once-daily capsule designed to release medication gradually throughout the day. That means it's not released in the body all at once, but rather over time.

Simtriyo has range and proven results

See Simtriyo results
-1

Keep up with the latest on [br-d] Simtriyo

Stay informed
-1
72
custom
10
/content/simtriyo/con/websites/com/about/About-Simtriyo-FAQ
4-8
1
1
custom
20px
custom
40px
custom
40px
stretch
1060px / 900px
center
false